✦ LIBER ✦

Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis

✍ Scribed by Hans L. Tillmann; Christian Trautwein; C.Thomas Bock; Isabella Glomb; Martin Krüger; Klaus H.W. Böker; Jürgen Klempnauer; Peer Flemming; Michael P. Manns

Book ID: 119392214
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 39 KB
Volume: 97
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)04144-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Entecavir significantly reduces viral lo

Entecavir significantly reduces viral load in liver transplant recipients failing lamivudine therapy for chronic hepatitis B infection

✍ Ahmad Obaid Shakil; Leslie Lilly; Peter Angus; Guido Gerken; Neal Thomas; Michel 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

444 PREVALENCE, RISK FACTORS AND OUTCOME

444 PREVALENCE, RISK FACTORS AND OUTCOME OF FIBROSING CHOLESTATIC HEPATITIS IN VIRAL CIRRHOSIS LIVER TRANSPLANT RECIPIENTS AT A REFERENCE CENTER FROM 2001–2008

✍ R. Bárcena; Ana Moreno; S. del Campo; C. Varona; M.L. Mateos; C. Quereda; J. Gra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A prospective cross-over study comparing

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

✍ Amany Zekry; Margret Gleeson; Seren Guney; Geoffrey W. McCaughan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

It has been suggested that Mycophenolate Mofetil (MMF) may have an antiviral effect in patients with recurrent HCV infection post-liver transplantation. We conducted a prospective cross-over study in liver transplant recipients with recurrent chronic HCV infection to examine whether substitution of